• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于液相色谱-高分辨质谱的脂质组学揭示了过氧化物酶体增殖物激活受体α在乙醛酸处理的小鼠肾结石形成中的保护作用。

Lipidomics based on liquid chromatography-high resolution mass spectrometry reveals the protective role of peroxisome proliferator-activated receptor alpha on kidney stone formation in mice treated with glyoxylate.

机构信息

School of Medicine, Shanghai University, Shanghai, China.

Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China.

出版信息

J Sep Sci. 2023 Dec;46(24):e2300452. doi: 10.1002/jssc.202300452. Epub 2023 Oct 25.

DOI:10.1002/jssc.202300452
PMID:37880903
Abstract

Few studies have examined the relationship between lipid metabolism and kidney stone formation, particularly the role of key lipid regulatory factors in kidney stone formation. We evaluated the effect of the lipid regulatory factor-peroxisome proliferator-activated receptor alpha on the formation of renal stones in mice by injecting them with glyoxylate followed by treatment with either a peroxisome proliferator-activated receptor alpha agonist fenofibrate or an antagonist GW6471 (GW). Liquid chromatography coupled with trapped ion mobility spectrometry-quadrupole-time-of-flight mass spectrometry-based lipidomics was used to determine the lipid profile in the mouse kidneys. Histological and biochemical analyses showed that the mice injected with glyoxylate exhibited crystal precipitation and renal dysfunction. Crystallization decreased significantly in the fenofibrate group, whereas it increased significantly in the GW group. A total of 184 lipids, including fatty acyls, glycerolipids, glycerophospholipids, and sphingolipids differed significantly between the mice in the model and control groups. Peroxisome proliferator-activated receptor alpha activity negatively correlated with glyoxylate-induced kidney stone formation in mice, which may be related to improved fatty acid oxidation, maintenance of ceramide/complex sphingolipids cycle balance, and alleviation of disorder in phospholipid metabolism.

摘要

很少有研究探讨脂质代谢与肾结石形成之间的关系,特别是关键脂质调节因子在肾结石形成中的作用。我们通过给小鼠注射乙醛酸,然后用过氧化物酶体增殖物激活受体α激动剂非诺贝特或拮抗剂 GW6471(GW)处理,评估脂质调节因子-过氧化物酶体增殖物激活受体α对小鼠肾结石形成的影响。采用液相色谱-串联离子淌度-四极杆飞行时间质谱脂质组学方法测定小鼠肾脏中的脂质谱。组织学和生化分析表明,注射乙醛酸的小鼠表现出晶体沉淀和肾功能障碍。在非诺贝特组中结晶明显减少,而在 GW 组中结晶明显增加。模型组和对照组小鼠之间共有 184 种脂质,包括脂肪酸、甘油酯、甘油磷脂和鞘脂,差异有统计学意义。过氧化物酶体增殖物激活受体α的活性与乙醛酸诱导的小鼠肾结石形成呈负相关,这可能与改善脂肪酸氧化、维持神经酰胺/复杂鞘脂循环平衡以及缓解磷脂代谢紊乱有关。

相似文献

1
Lipidomics based on liquid chromatography-high resolution mass spectrometry reveals the protective role of peroxisome proliferator-activated receptor alpha on kidney stone formation in mice treated with glyoxylate.基于液相色谱-高分辨质谱的脂质组学揭示了过氧化物酶体增殖物激活受体α在乙醛酸处理的小鼠肾结石形成中的保护作用。
J Sep Sci. 2023 Dec;46(24):e2300452. doi: 10.1002/jssc.202300452. Epub 2023 Oct 25.
2
Untargeted lipidomics based on UPLC-QTOF-MS/MS and structural characterization reveals dramatic compositional changes in serum and renal lipids in mice with glyoxylate-induced nephrolithiasis.基于 UPLC-QTOF-MS/MS 的非靶向脂质组学和结构特征分析揭示了乙醛酸诱导的肾结石小鼠血清和肾脏脂质组成的显著变化。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Sep 15;1095:258-266. doi: 10.1016/j.jchromb.2018.08.003. Epub 2018 Aug 7.
3
STAT6 promoting oxalate crystal deposition-induced renal fibrosis by mediating macrophage-to-myofibroblast transition via inhibiting fatty acid oxidation.STAT6 通过抑制脂肪酸氧化介导线粒体转位促进草酸钙晶体沉积诱导的肾纤维化。
Inflamm Res. 2023 Dec;72(12):2111-2126. doi: 10.1007/s00011-023-01803-2. Epub 2023 Nov 4.
4
PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate.PPARα 依赖性降脂药非诺贝特加重实验性结肠炎。
Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1;307(5):G564-73. doi: 10.1152/ajpgi.00153.2014. Epub 2014 Jul 17.
5
Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.过氧化物酶体增殖物激活受体-α 选择性调节剂 K-877 能有效激活过氧化物酶体增殖物激活受体-α 通路,改善小鼠的脂代谢。
J Diabetes Investig. 2017 Jul;8(4):446-452. doi: 10.1111/jdi.12621. Epub 2017 Apr 25.
6
The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice.肝脏因子FGF21对于过氧化物酶体增殖物激活受体-α激动剂诱导肥胖小鼠代谢紊乱的改善至关重要。
J Biol Chem. 2017 Jun 2;292(22):9175-9190. doi: 10.1074/jbc.M116.767590. Epub 2017 Apr 12.
7
MiR-21 promotes calcium oxalate-induced renal tubular cell injury by targeting PPARA.miR-21 通过靶向 PPARA 促进草酸钙诱导的肾小管细胞损伤。
Am J Physiol Renal Physiol. 2020 Aug 1;319(2):F202-F214. doi: 10.1152/ajprenal.00132.2020. Epub 2020 Jul 6.
8
Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor and Peroxisome Proliferator-Activated Receptor Coactivator 1-Dependent Gene Expression to Increase Blood Triglyceride Levels.抗癫痫药物激活的组成型雄烷受体抑制过氧化物酶体增殖物激活受体和过氧化物酶体增殖物激活受体共激活物 1 依赖性基因表达,增加血液甘油三酯水平。
Mol Pharmacol. 2020 Nov;98(5):634-647. doi: 10.1124/molpharm.120.000103. Epub 2020 Sep 5.
9
Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.过氧化物酶体增殖物激活受体-α基因水平差异影响载脂蛋白 E2 基因敲入小鼠的脂代谢和炎症反应。
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1573-9. doi: 10.1161/ATVBAHA.110.220525. Epub 2011 Apr 7.
10
Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.过氧化物酶体增殖物激活受体-α激活可减轻 3-硝基丙酸诱导的大鼠行为和生化改变:可能的神经保护机制。
Eur J Pharmacol. 2012 Jan 5;674(1):33-43. doi: 10.1016/j.ejphar.2011.10.029. Epub 2011 Oct 26.

引用本文的文献

1
Dysregulated lipid metabolism in kidney stone pathogenesis: a literature review of mechanistic insights and therapeutic implications.肾结石发病机制中脂质代谢失调:机制见解与治疗意义的文献综述
BMC Urol. 2025 Aug 18;25(1):203. doi: 10.1186/s12894-025-01870-z.
2
Serum metabolomics study reveals a distinct metabolic diagnostic model for renal calculi.血清代谢组学研究揭示了一种独特的肾结石代谢诊断模型。
Heliyon. 2024 Jun 8;10(11):e32482. doi: 10.1016/j.heliyon.2024.e32482. eCollection 2024 Jun 15.